Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Isomorphic Labs

Isomorphic Labs Secures $5 Billion in Series C+ Funding Round Led by Sequoia Capital

November 17, 2026 by James O'Brien

Isomorphic Labs, the London‑based AI drug‑discovery startup spun out of DeepMind, announced a $5 billion financing round led by Sequoia Capital with participation from Andreessen Horowitz, marking one of the largest recent raises for a European deep‑tech venture.

Categories Funding Tags €100M+, Deeptech, Isomorphic Labs, Series C+, United Kingdom Leave a comment

Browse by Country

Latest

French Li-Fi Startup Oledcomm Pivots to Defence, Wins NATO Recognition and French Army ContractNov 18, 2026
Glovo Expands Beyond Food Delivery Into Fashion, Pharmacy and Pet Care With Fintech PartnershipNov 18, 2026
Romanian Social Media Startup eYou Wins EU Trust Badge, Secures Over €6.5 Million in FundingNov 18, 2026
Copenhagen Sports Platform Bricks Performance Secures Investment to Expand Across Nordic RegionNov 18, 2026
Romanian Solar Company Simtel Team Rebrands as SMTL Group, Restructures OperationsNov 18, 2026

EU Markets

European Startups Navigate a Week of Big Money Moves, Regulatory Shifts, and Market TurbulenceNov 13, 2026
Europe's Financial Pulse: AI Bets, Rate Signals, and What Founders Need to Know This WeekNov 6, 2026
European Markets Flash Caution Signals: What This Week's Financial Turbulence Means for Startup FoundersOct 30, 2026
European Startups, Brace Yourselves: Rate Pressures, AI Disruption, and a €550M Legal Tech Unicorn Define This Week's Financial LandscapeOct 23, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.